I don't think I am in any way a ramper (having been in this stock for more than a decade I have learned not to get too pumped) however, I did have expectations that financial stability would get the stock re-rated and the price in the high 30's.
I have been totally underwhelmed by the inability of management to provide the market with any sort of production data to base any type of cash flow forecasts on. They completed the Amgen deal, kudos for that, but we are supposed to have lines running, pumping out devices - AT THE SAME TIME as we are getting the finances back into some sort of cohesive, sustainable state.
A company has many simultaneously moving parts. Our mob seem to think one issue at a time will keep the market happy. Is it any wonder that the share price is where it is.
I look forward to some guidance from the crew on our operational performance and forecasts within the next 30 days.
UNS Price at posting:
18.5¢ Sentiment: Hold Disclosure: Held
